Atlas Trials

Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis

Clinical trial NCT03130127 · UNKNOWN

Trial details

NCT number
NCT03130127
Sponsor
General Hospital of Shenyang Military Region
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver CirrhosisPortal HypertensionVariceal HemorrhageBleedingEsophageal and Gastric Varices
Start date
2024-07-01
Primary completion
2025-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.